Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine

Kidney Cancer Clinical Trials

A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 4 5 6 7 Last 

Arizona

Research Site
Scottsdale Arizona 85259

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tucson Arizona 85724

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Scottsdale Arizona 85258

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Scottsdale Arizona 85259-5499

A clinical trial to evaluate treatments using hypoxia-activated prodrug TH-302, sorafenib tosylate, protein analysis and laboratory biomarker analysis for patients with Kidney Cancer or Liver Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Arkansas

Research Site
Little Rock Arkansas 72205

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

California

Research Site
La Jolla California 92093-0698

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90048

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90024

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
San Francisco California 94115

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Stanford California 94305-5334

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

La Jolla California 92093

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Los Angeles California 90024

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Stanford California 94305

A Phase 2 clinical study for patients with Genitourinary Cancer or Kidney Cancer

Colorado

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Colorado Springs Colorado 80909

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Denver Colorado 80211

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Parker Colorado 80134

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Colorado Springs Colorado 80909

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Denver Colorado 80211

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Parker Colorado 80134

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Connecticut

Research Site
Hartford Connecticut 06102-5037

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Hartford Connecticut 06102

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Florida

Research Site
Miami Florida 33140

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tampa Florida 33612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Miami Florida 33140

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Georgia

Research Site
Atlanta Georgia 30322

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Augusta Georgia 30912

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Lenalidomide and Everolimus to evaluate Solid Organ Malignancies

Augusta Georgia 30912

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Idaho

Research Site
Boise Idaho 83706

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Meridian Idaho 83642

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Boise Idaho 83706

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Meridian Idaho 83642

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Illinois

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60640

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Hines Illinois 60141

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Maywood Illinois 60153

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Skokie Illinois 60076

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Springfield Illinois 62702

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More ▼

Chicago Illinois 60612

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

First 1 2 3 4 5 6 7 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.